Ligand validation:3U16

MRD: (4R)-2-METHYLPENTANE-2,4-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3U16_MRD_B_546	46%	86%	0.139	0.875	0.3	0.41	-	-	3	0	100%	1
3O83_MRD_B_546	58%	88%	0.129	0.907	0.29	0.38	-	-	0	0	100%	1
3U17_MRD_B_547	57%	79%	0.161	0.935	0.33	0.54	-	-	0	0	100%	1
3O84_MRD_B_544	9%	89%	0.281	0.766	0.25	0.38	-	-	0	0	100%	1
6B6R_MRD_A_307	100%	70%	0.037	0.984	0.6	0.57	-	-	0	0	100%	1
2BJK_MRD_A_1519	100%	71%	0.042	0.985	0.5	0.61	-	-	0	0	100%	1
9NK3_MRD_A_203	100%	68%	0.042	0.984	0.43	0.8	-	-	2	0	100%	1
5SZD_MRD_A_102	98%	93%	0.06	0.984	0.3	0.17	-	-	0	0	100%	1
4DUI_MRD_A_202	98%	59%	0.06	0.982	0.8	0.79	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.